Zobrazeno 1 - 10
of 11
pro vyhledávání: '"RB Gadelha"'
Autor:
FMCP Pessoa, IV Barreto, RB Gadelha, CB Machado, BMD Nogueira, AKC Machado, MEA Morais, MOM Filho, DS Oliveira, CA Moreir-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S262- (2023)
Objetivo: Atualmente, a ampla aplicação da imunofenotipagem e caracterização genética tornou-se fundamental para refinamento diagnóstico, estratificação de risco, predição de prognóstico e promoção de terapia-alvo em pacientes com Leucem
Externí odkaz:
https://doaj.org/article/396b0e483a8e432e91f1d83f3cf80645
Autor:
RB Gadelha, BMD Nogueira, FMCP Pessoa, AKC Machado, IV Barreto, RM Ribeiro, GS Lopes, MEA Moraes, MOM Filho, CA Moreir-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S300-S301 (2023)
Objetivos: A classificação da leucemia mieloide aguda (LMA) é baseada principalmente nas alterações citogenéticas; Sua classificação é necessária para uma estratificação de risco, o que, por sua vez, desempenha um papel relevante no progn
Externí odkaz:
https://doaj.org/article/537cbf0ef02545f78d700d46ce68de4f
Autor:
FMCP Pessoa, IV Barreto, RB Gadelha, CB Machado, BMD Nogueira, AKC Machado, RM Ribeiro, MEA Moraes, MOM Filho, CA Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S314- (2023)
Objetivo: Diante da importância da detecção de alterações genéticas em pacientes com leucemias, o objetivo desse estudo foi comparar a sensibilidade das técnicas Nested -PCR e RT-qPCR na detecção de alterações genéticas em pacientes porta
Externí odkaz:
https://doaj.org/article/5f4d1b8f0f9649d4b54365a66c899b3c
Autor:
FMCP Pessoa, IV Barreto, RB Gadelha, BMD Nogueira, AKC Machado, RM Ribeiro, DS Oliveira, MEA Moraes, CA Moreira-Nunes, MOM Filho
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S315- (2023)
Objetivo: Atualmente, a ampla aplicação da imunofenotipagem e caracterização genética tornou-se fundamental para refinamento diagnóstico, estratificação de risco, predição de prognóstico e promoção de terapia-alvo em pacientes com Leucem
Externí odkaz:
https://doaj.org/article/1d0e5ead36e54c88b9ab8a05972cf463
Autor:
IV Barreto, BMD Nogueira, FMCP Pessoa, RB Gadelha, AKC Machado, RM Ribeiro, APL Moreira, MEA Moraes, MOM Filho, CS Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S422-S423 (2023)
Objetivo: O mieloma múltiplo (MM) é a segunda neoplasia hematológica mais frequente no mundo, possuindo dentre seus sintomas característicos como anemia e disfunção renal. Com isso o objetivo deste trabalho é avaliar dados laboratoriais de pac
Externí odkaz:
https://doaj.org/article/2c10287aa15b41dab1c07055e0aadcae
Autor:
FMCP Pessoa, CB Machado, IV Barreto, RB Gadelha, RM Ribeiro, DS Oliveira, MOM Filho, RC Montenegro, MEA Moraes, CA Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S166-S167
Autor:
FMCP Pessoa, CB Machado, IV Barreto, RB Gadelha, RM Ribeiro, DS Oliveira, MOM Filho, RC Montenegro, MEA Moraes, CA Moreira-Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy. 44:S167
Autor:
DE Pinho Pessoa FMC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Nogueira BMD; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Barreto IV; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DA Costa Machado AK; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Gadelha RB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Sousa Oliveira D; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Silva FAC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Gurgel LA; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Medeiros JC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., DA Rocha Maciel A; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza, CE, Brazil., Vieira RPG; Department of Hematology, São Vicente de Paulo Maternity Hospital, Barbalha, CE, Brazil., DE Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil., Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil; carolfam@gmail.com.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil.; Clementino Fraga Group, Central Unity, Molecular Biology Laboratory, Fortaleza, CE, Brazil.
Publikováno v:
In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 2016-2023.
Autor:
DA Costa Machado AK; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Pinho Pessoa FMC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Barreto IV; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Gadelha RB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Sousa Oliveira D; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza, CE, Brazil., DE Moraesfilho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil., Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil.; Clementino Fraga Group, Central Unity, Molecular Biology Laboratory, Fortaleza, CE, Brazil.
Publikováno v:
Cancer diagnosis & prognosis [Cancer Diagn Progn] 2024 Jan 03; Vol. 4 (1), pp. 9-24. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2024).
Autor:
Gadelha RB; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Machado CB; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Pessoa FMCP; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Pantoja LDC; Department of Pediatrics, Octávio Lobo Children's Hospital, Belém 60430-275, PA, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil., Barreto IV; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza 60150-160, CE, Brazil., de Moraes Filho MO; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., de Moraes MEA; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil., Moreira-Nunes CA; Pharmacogenetics Laboratory, Department of Medicine, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza 60430-275, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém 66073-005, PA, Brazil.; Northeast Biotechnology Network (RENORBIO), Itaperi Campus, Ceará State University, Fortaleza 60740-903, CE, Brazil.
Publikováno v:
Current issues in molecular biology [Curr Issues Mol Biol] 2022 Nov 04; Vol. 44 (11), pp. 5498-5515. Date of Electronic Publication: 2022 Nov 04.